DE69333711D1 - Compactin zur behandlung von entzündungen - Google Patents

Compactin zur behandlung von entzündungen

Info

Publication number
DE69333711D1
DE69333711D1 DE69333711T DE69333711T DE69333711D1 DE 69333711 D1 DE69333711 D1 DE 69333711D1 DE 69333711 T DE69333711 T DE 69333711T DE 69333711 T DE69333711 T DE 69333711T DE 69333711 D1 DE69333711 D1 DE 69333711D1
Authority
DE
Germany
Prior art keywords
compactin
ignitions
treating
inhibitors
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69333711T
Other languages
English (en)
Other versions
DE69333711T2 (de
Inventor
M Bokoch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of DE69333711D1 publication Critical patent/DE69333711D1/de
Application granted granted Critical
Publication of DE69333711T2 publication Critical patent/DE69333711T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Ignition Installations For Internal Combustion Engines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69333711T 1992-01-31 1993-01-21 Compactin zur behandlung von entzündungen Expired - Fee Related DE69333711T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US829766 1992-01-31
US07/829,766 US5244916A (en) 1992-01-31 1992-01-31 Inhibition of respiratory burst using posttranslational modification inhibitors
PCT/US1993/000871 WO1993014749A1 (en) 1992-01-31 1993-01-21 Inhibition of respiratory burst using posttranslational modification inhibitors

Publications (2)

Publication Number Publication Date
DE69333711D1 true DE69333711D1 (de) 2004-12-30
DE69333711T2 DE69333711T2 (de) 2005-12-15

Family

ID=25255499

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333711T Expired - Fee Related DE69333711T2 (de) 1992-01-31 1993-01-21 Compactin zur behandlung von entzündungen

Country Status (6)

Country Link
US (1) US5244916A (de)
EP (1) EP0727987B1 (de)
AT (1) ATE283044T1 (de)
CA (1) CA2129235C (de)
DE (1) DE69333711T2 (de)
WO (1) WO1993014749A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470877A (en) * 1992-04-09 1995-11-28 Wisconsin Alumni Research Foundation Uses of perillic acid methyl ester
US5587402A (en) * 1992-04-09 1996-12-24 Wisconsin Alumni Research Foundation Regression of mammalian leukemia cell tumors
US5726155A (en) * 1993-08-02 1998-03-10 The Scripps Research Institute Regulation of oxidative burst using LMWG-derived peptides and analogs
US5668171A (en) * 1993-11-08 1997-09-16 Board Of Regents, The University Of Texas System Halogenated mevalonate compositions and uses thereof in ras-dependent cell growth
GB2285047B (en) * 1993-12-21 1998-04-15 Yamanouchi U K Ltd Polypeptides which inhibit the NADPH oxidase complex
US5763496A (en) * 1995-11-27 1998-06-09 The Research Foundation Of State University Of New York Prevention of atherosclerosis using NADPH oxidase inhibitors
WO1999026657A1 (en) 1997-11-25 1999-06-03 Musc Foundation For Research Development Inhibitors of nitric oxide synthase
US8679534B2 (en) * 1997-12-12 2014-03-25 Andrx Labs, Llc HMG-CoA reductase inhibitor extended release formulation
US20040029962A1 (en) * 1997-12-12 2004-02-12 Chih-Ming Chen HMG-COA reductase inhibitor extended release formulation
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
US20010006656A1 (en) * 1999-02-17 2001-07-05 University Of Washington Methods and compositions for inhibiting inflammation associated with pulmonary disease
AU768950B2 (en) * 1999-11-08 2004-01-08 Andrx Corporation HMG-COA reductase inhibitor extended release formulation
US20020010128A1 (en) * 2000-04-13 2002-01-24 Parks Thomas P. Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
US20030195167A1 (en) * 2002-04-15 2003-10-16 Kowa Co., Ltd. PTX3-gene expression inhibitor
US20150328185A1 (en) 2012-08-22 2015-11-19 Universidad De Los Andes Use of statins for periodontaldisesae and bone regeneration
FR3030248B1 (fr) 2014-12-22 2018-03-23 L'oreal Association derive d'acide pyridine-dicarboxylique/agent anti-oxydant particulier

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2111384A (en) * 1981-08-03 1983-07-06 Wynne David Improvement in preventative and curative medicine
US5593966A (en) * 1989-03-31 1997-01-14 The United States Of America As Represented By The Department Of Health And Human Services Peptide derivatives of cytochrome b558 and their use as medicaments
AU7699191A (en) * 1990-03-30 1991-10-30 Amgen, Inc. Respiratory burst suppression factor
WO1993025186A1 (en) * 1992-06-16 1993-12-23 Klein Marvin E Composition for the treatment of skin
JP2004351839A (ja) * 2003-05-30 2004-12-16 Brother Ind Ltd 接合構造及び接合構造の製造方法

Also Published As

Publication number Publication date
ATE283044T1 (de) 2004-12-15
CA2129235C (en) 2004-04-06
DE69333711T2 (de) 2005-12-15
EP0727987A1 (de) 1996-08-28
AU3602793A (en) 1993-09-01
US5244916A (en) 1993-09-14
CA2129235A1 (en) 1993-08-05
AU670259B2 (en) 1996-07-11
EP0727987B1 (de) 2004-11-24
WO1993014749A1 (en) 1993-08-05
EP0727987A4 (de) 1998-03-11

Similar Documents

Publication Publication Date Title
DE69333711D1 (de) Compactin zur behandlung von entzündungen
ATE208210T1 (de) Kombination von proteintyrosin-kinaseinhibitoren und chemischer kastration zur behandlung von prostatakrebs
NO962187L (no) Sammensetninger som inhiberer apoptose, fremgangsmåter for rensing av sammensetningene og anvendelse derav
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
BG102738A (en) Inhibitors of farnesyl-protein transferase
BG102872A (en) 6-phenylpyridyl-3-amine derivatives
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
EP0677048A1 (de) Cyclische sulfone als inhibitoren retroviralen proteasen.
DK0705100T3 (da) Terapeutiske substituerede guanidiner
DE69214610D1 (de) Verfahren zur Behandlung von Erdgas
DE60229406D1 (de) Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
DE69707033T2 (de) Verfahren zur Behandlung von Gasen die Organohalogenzusammensetzungen enthalten
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
JO1696B1 (en) Acetamide derivatives
DE69635114D1 (de) Proteinfarnesyltransferase-inhibitoren in kombination mit hmgcoa-reduktase-inhibitoren zur behandlung von aids
ATE232191T1 (de) Verfahren und zusammensetzung zur inhibierung der polymerisierung von ethylenisch ungesättigten kohlenwasserstoffen
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
NO984075D0 (no) Kombinasjon av dehydroepiandrosteron og aromatasehemmere og anvendelse av denne kombinasjon for fremstilling av et legemiddel for behandling av en relativ og absolutt androgen mangel hos menn
DE69228814D1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
ATE244008T1 (de) Verwendung von makroliden zur behandlung von akuten lungenverletzungen
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
DE69301936D1 (de) Verfahren zur Behandlung von Rauchgas
NO982582L (no) Fremgangsmaate for behandling av smerte

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee